文献速递复苏、休克与脓毒症心脑血管急症

除颤波形与除颤时间或除颤次数对院外心脏骤停生存率的交互作用

Interaction of defibrillation waveform with the time to defibrillation or the number of defibrillation attempts on survival from out-of-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2017-11-24
一句话结论日本院外心脏骤停观察性研究显示,双相波除颤在需两次及以上除颤时长期生存优于单相波,除颤次数增加仅与双相波组1个月生存率和CPC(1,2)升高相关。

该前瞻性观察研究纳入2005至2014年日本全部院外心脏骤停病例,共71,566例符合标准,分析除颤波形与首次除颤时间或除颤次数对自主循环恢复(ROSC)、1个月生存和脑功能分级(CPC 1,2)的交互作用。结果显示,除颤波形对首次除颤时间与ROSC的关联呈负向修饰,比值比为0.84(0.75-0.94)。除颤波形对除颤次数与CPC(1,2)的关联亦呈负向修饰,RERI为-0.25(-0.47至-0.06),比值比为0.79(0.67-0.93)。结论提示,除颤次数增加与双相波和单相波组ROSC降低均相关,但仅双相波组除颤次数增加与1个月生存率和CPC(1,2)升高相关;需两次及以上除颤时双相波长期生存优于单相波。

要点

  • 需两次及以上除颤时,双相波在长期生存方面比单相波更有效。
  • 除颤次数增加与双相波和单相波组的ROSC降低均相关。
  • 仅双相波组中,除颤次数增加与1个月生存率升高和CPC(1,2)升高相关。
  • 除颤波形对首次除颤时间与ROSC的关联呈负向修饰,比值比0.84(0.75-0.94)。
  • 除颤波形对除颤次数与CPC(1,2)的关联呈负向修饰,RERI -0.25(-0.47至-0.06),比值比0.79(0.67-0.93)。

适用人群与场景

  • 2005至2014年日本全部院外心脏骤停(OHCA)病例,共71,566例符合纳入标准。
  • 在日本,第二次及后续除颤需由在线医生实施。

研究设计与关键结果

  • 前瞻性观察研究,纳入2005至2014年日本全部OHCA病例,共71,566例符合纳入标准。
  • 除颤波形与首次除颤时间对ROSC的交互作用:比值比0.84(0.75-0.94),提示除颤波形对首次除颤时间与ROSC的关联呈负向修饰。
  • 除颤波形与除颤次数对CPC(1,2)的交互作用:RERI -0.25(-0.47至-0.06),比值比0.79(0.67-0.93),提示除颤波形对除颤次数与CPC(1,2)的关联呈负向修饰。
  • 除颤次数增加与双相波和单相波组的ROSC降低均相关;仅双相波组中除颤次数增加与1个月生存率升高和CPC(1,2)升高相关。
  • 需两次及以上除颤时,双相波在长期生存方面比单相波更有效。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论提示,需两次及以上除颤时双相波在长期生存方面比单相波更有效。
  • 原文结论提示,除颤次数增加与双相波和单相波组ROSC降低均相关,但仅双相波组除颤次数增加与1个月生存率和CPC(1,2)升高相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Early biphasic defibrillation is effective in out-of-hospital cardiac arrest (OHCA) cases. In the resuscitation of patients with OHCA, it is not clear how the defibrillation waveform interacts with the time to defibrillation to influence patient survival. The second, and any subsequent, shocks need to be administered by an on-line physician in Japan. Thus, we investigated the interaction between the defibrillation waveform and time to or the number of defibrillation on resuscitation outcomes.

METHODS: This prospective observational study used data for all OHCAs that occurred between 2005 and 2014 in Japan. To investigate the interaction effect between the defibrillation waveform and the time to defibrillation or the number of defibrillations on the return to spontaneous circulation (ROSC), 1-month survival, and cerebral performance category (CPC) (1, 2), we assessed the modifying effects of the defibrillation waveform and the time to or the number of defibrillation on additive scale (i.e., the relative excessive risk due to interaction, RERI) and multiplicative scale (i.e., ratio of odds ratios (ORs)).

RESULTS: In total, 71,566 cases met the inclusion criteria. For the measure of interaction between the defibrillation waveform and the time to defibrillation, ratio of ORs for ROSC was 0.84 (0.75-0.94), implying that the effect of time to first defibrillation on ROSC was negatively modified by defibrillation waveform. For the interaction between the defibrillation waveform and the number of defibrillations, RERI and ratio of ORs for CPC (1, 2) was -0.25 (-0.47 to -0.06) and 0.79 (0.67-0.93), respectively. It is implied that the effect of number of defibrillation on CPC (1, 2) was negatively modified by defibrillation waveform.

CONCLUSIONS: An increased number of defibrillations was associated with a decreased ROSC in the case of biphasic and monophasic defibrillation, while an increased number of defibrillations was related to an increased 1-month survival rate and CPC (1, 2) only in the case of biphasic defibrillation. When two or more defibrillations were performed, a biphasic waveform was more effective in terms of long-term survival than a monophasic waveform.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Hagihara A, Onozuka D, Ono J, et al. Interaction of defibrillation waveform with the time to defibrillation or the number of defibrillation attempts on survival from out-of-hospital cardiac arrest. Resuscitation. 2017. PMID: 29175354. doi:10.1016/j.resuscitation.2017.11.053

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。